Home/Filings/4/0000950170-23-032871

4//SEC Filing

AFEYAN NOUBAR 4

Accession 0000950170-23-032871

CIK 0001694665other

View on SEC.gov Company Profile

Filed

Jul 12, 8:00 PM ET

Accepted

Jul 13, 5:15 PM ET

Size

31.9 KB

Accession

0000950170-23-032871

Insider Transaction Report

Form 4

Period: 2023-07-11

Evelo Biosciences, Inc.EVLO

Nutritional Health LTP Fund, L.P.

10% Owner

Transactions

Purchase
Common Stock
2023-07-11$2.31/sh+3,246,753$7,499,999→ 3,931,685 total(indirect: By Flagship Pioneering Fund VII, L.P.)
Purchase
Common Stock
2023-07-11$2.31/sh+1,082,251$2,500,000→ 1,461,795 total(indirect: By Flagship Ventures Fund IV, L.P.)
Purchase
Common Stock
2023-07-11$2.31/sh+1,082,251$2,500,000→ 1,493,241 total(indirect: By Nutritional Health LTP Fund, L.P.)

Holdings

Common Stock
(indirect: By Flagship Ventures Opportunities Fund I, L.P.)
274,766
Common Stock
(indirect: By LLC)
132,282
Common Stock
(indirect: By Flagship Ventures Fund IV-Rx, L.P.)
94,371
Common Stock
(indirect: By LLC)
34,219
Common Stock
(indirect: By Flagship V VentureLabs Rx Fund, L.P.)
80,494
Common Stock
(indirect: By Nutritional Health Side Fund, L.P.)
39,798
Common Stock
(indirect: By Nutritional Health Disruptive Innovation Fund, L.P.)
179,909
Common Stock
(indirect: By Flagship Ventures Fund V, L.P.)
210,064

Flagship Pioneering Fund VII General Partner LLC

10% Owner

Transactions

Purchase
Common Stock
2023-07-11$2.31/sh+1,082,251$2,500,000→ 1,493,241 total(indirect: By Nutritional Health LTP Fund, L.P.)
Purchase
Common Stock
2023-07-11$2.31/sh+1,082,251$2,500,000→ 1,461,795 total(indirect: By Flagship Ventures Fund IV, L.P.)
Purchase
Common Stock
2023-07-11$2.31/sh+3,246,753$7,499,999→ 3,931,685 total(indirect: By Flagship Pioneering Fund VII, L.P.)

Holdings

Common Stock
(indirect: By LLC)
34,219
Common Stock
(indirect: By LLC)
132,282
Common Stock
(indirect: By Flagship Ventures Fund V, L.P.)
210,064
Common Stock
(indirect: By Nutritional Health Disruptive Innovation Fund, L.P.)
179,909
Common Stock
(indirect: By Flagship Ventures Opportunities Fund I, L.P.)
274,766
Common Stock
(indirect: By Nutritional Health Side Fund, L.P.)
39,798
Common Stock
(indirect: By Flagship Ventures Fund IV-Rx, L.P.)
94,371
Common Stock
(indirect: By Flagship V VentureLabs Rx Fund, L.P.)
80,494

Flagship Ventures Fund IV General Partner LLC

10% Owner

Transactions

Purchase
Common Stock
2023-07-11$2.31/sh+1,082,251$2,500,000→ 1,493,241 total(indirect: By Nutritional Health LTP Fund, L.P.)
Purchase
Common Stock
2023-07-11$2.31/sh+3,246,753$7,499,999→ 3,931,685 total(indirect: By Flagship Pioneering Fund VII, L.P.)
Purchase
Common Stock
2023-07-11$2.31/sh+1,082,251$2,500,000→ 1,461,795 total(indirect: By Flagship Ventures Fund IV, L.P.)

Holdings

Common Stock
(indirect: By Flagship Ventures Opportunities Fund I, L.P.)
274,766
Common Stock
(indirect: By Flagship Ventures Fund IV-Rx, L.P.)
94,371
Common Stock
(indirect: By LLC)
132,282
Common Stock
(indirect: By Flagship Ventures Fund V, L.P.)
210,064
Common Stock
(indirect: By Nutritional Health Side Fund, L.P.)
39,798
Common Stock
(indirect: By LLC)
34,219
Common Stock
(indirect: By Flagship V VentureLabs Rx Fund, L.P.)
80,494
Common Stock
(indirect: By Nutritional Health Disruptive Innovation Fund, L.P.)
179,909

Flagship Ventures Fund IV, L.P.

10% Owner

Transactions

Purchase
Common Stock
2023-07-11$2.31/sh+1,082,251$2,500,000→ 1,461,795 total(indirect: By Flagship Ventures Fund IV, L.P.)
Purchase
Common Stock
2023-07-11$2.31/sh+1,082,251$2,500,000→ 1,493,241 total(indirect: By Nutritional Health LTP Fund, L.P.)
Purchase
Common Stock
2023-07-11$2.31/sh+3,246,753$7,499,999→ 3,931,685 total(indirect: By Flagship Pioneering Fund VII, L.P.)

Holdings

Common Stock
(indirect: By LLC)
132,282
Common Stock
(indirect: By Nutritional Health Disruptive Innovation Fund, L.P.)
179,909
Common Stock
(indirect: By Flagship Ventures Fund IV-Rx, L.P.)
94,371
Common Stock
(indirect: By LLC)
34,219
Common Stock
(indirect: By Flagship Ventures Opportunities Fund I, L.P.)
274,766
Common Stock
(indirect: By Flagship Ventures Fund V, L.P.)
210,064
Common Stock
(indirect: By Flagship V VentureLabs Rx Fund, L.P.)
80,494
Common Stock
(indirect: By Nutritional Health Side Fund, L.P.)
39,798

Nutritional Health LTP Fund General Partner LLC

10% Owner

Transactions

Purchase
Common Stock
2023-07-11$2.31/sh+3,246,753$7,499,999→ 3,931,685 total(indirect: By Flagship Pioneering Fund VII, L.P.)
Purchase
Common Stock
2023-07-11$2.31/sh+1,082,251$2,500,000→ 1,461,795 total(indirect: By Flagship Ventures Fund IV, L.P.)
Purchase
Common Stock
2023-07-11$2.31/sh+1,082,251$2,500,000→ 1,493,241 total(indirect: By Nutritional Health LTP Fund, L.P.)

Holdings

Common Stock
(indirect: By Flagship Ventures Fund IV-Rx, L.P.)
94,371
Common Stock
(indirect: By Flagship Ventures Fund V, L.P.)
210,064
Common Stock
(indirect: By Flagship V VentureLabs Rx Fund, L.P.)
80,494
Common Stock
(indirect: By Nutritional Health Side Fund, L.P.)
39,798
Common Stock
(indirect: By LLC)
132,282
Common Stock
(indirect: By LLC)
34,219
Common Stock
(indirect: By Flagship Ventures Opportunities Fund I, L.P.)
274,766
Common Stock
(indirect: By Nutritional Health Disruptive Innovation Fund, L.P.)
179,909

Flagship Pioneering, LLC

10% Owner

Transactions

Purchase
Common Stock
2023-07-11$2.31/sh+3,246,753$7,499,999→ 3,931,685 total(indirect: By Flagship Pioneering Fund VII, L.P.)
Purchase
Common Stock
2023-07-11$2.31/sh+1,082,251$2,500,000→ 1,461,795 total(indirect: By Flagship Ventures Fund IV, L.P.)
Purchase
Common Stock
2023-07-11$2.31/sh+1,082,251$2,500,000→ 1,493,241 total(indirect: By Nutritional Health LTP Fund, L.P.)

Holdings

Common Stock
(indirect: By Flagship Ventures Opportunities Fund I, L.P.)
274,766
Common Stock
(indirect: By LLC)
132,282
Common Stock
(indirect: By Flagship V VentureLabs Rx Fund, L.P.)
80,494
Common Stock
(indirect: By Flagship Ventures Fund IV-Rx, L.P.)
94,371
Common Stock
(indirect: By LLC)
34,219
Common Stock
(indirect: By Nutritional Health Side Fund, L.P.)
39,798
Common Stock
(indirect: By Flagship Ventures Fund V, L.P.)
210,064
Common Stock
(indirect: By Nutritional Health Disruptive Innovation Fund, L.P.)
179,909

Flagship Pioneering Fund VII, L.P.

10% Owner

Transactions

Purchase
Common Stock
2023-07-11$2.31/sh+3,246,753$7,499,999→ 3,931,685 total(indirect: By Flagship Pioneering Fund VII, L.P.)
Purchase
Common Stock
2023-07-11$2.31/sh+1,082,251$2,500,000→ 1,461,795 total(indirect: By Flagship Ventures Fund IV, L.P.)
Purchase
Common Stock
2023-07-11$2.31/sh+1,082,251$2,500,000→ 1,493,241 total(indirect: By Nutritional Health LTP Fund, L.P.)

Holdings

Common Stock
(indirect: By LLC)
34,219
Common Stock
(indirect: By Nutritional Health Disruptive Innovation Fund, L.P.)
179,909
Common Stock
(indirect: By Flagship Ventures Opportunities Fund I, L.P.)
274,766
Common Stock
(indirect: By Flagship Ventures Fund IV-Rx, L.P.)
94,371
Common Stock
(indirect: By Flagship Ventures Fund V, L.P.)
210,064
Common Stock
(indirect: By LLC)
132,282
Common Stock
(indirect: By Flagship V VentureLabs Rx Fund, L.P.)
80,494
Common Stock
(indirect: By Nutritional Health Side Fund, L.P.)
39,798

AFEYAN NOUBAR

Director10% Owner

Transactions

Purchase
Common Stock
2023-07-11$2.31/sh+1,082,251$2,500,000→ 1,461,795 total(indirect: By Flagship Ventures Fund IV, L.P.)
Purchase
Common Stock
2023-07-11$2.31/sh+3,246,753$7,499,999→ 3,931,685 total(indirect: By Flagship Pioneering Fund VII, L.P.)
Purchase
Common Stock
2023-07-11$2.31/sh+1,082,251$2,500,000→ 1,493,241 total(indirect: By Nutritional Health LTP Fund, L.P.)

Holdings

Common Stock
(indirect: By Flagship Ventures Fund IV-Rx, L.P.)
94,371
Common Stock
(indirect: By Flagship Ventures Opportunities Fund I, L.P.)
274,766
Common Stock
(indirect: By LLC)
132,282
Common Stock
(indirect: By Flagship Ventures Fund V, L.P.)
210,064
Common Stock
(indirect: By Flagship V VentureLabs Rx Fund, L.P.)
80,494
Common Stock
(indirect: By LLC)
34,219
Common Stock
(indirect: By Nutritional Health Side Fund, L.P.)
39,798
Common Stock
(indirect: By Nutritional Health Disruptive Innovation Fund, L.P.)
179,909

Footnotes (12)

[F1]On July 11, 2023, Flagship Ventures Fund IV, L.P. ("Flagship Fund IV"), Nutritional Health LTP Fund, L.P. ("Nutritional LTP") and Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") acquired 1,082,251 shares, 1,082,251 shares and 3,246,753 shares, respectively, of the Issuer's Common Stock in a private placement at a price of $2.31 per share.
[F10]Shares held by Flagship V VentureLabs Rx Fund, L.P. ("VentureLabs Rx V"). Flagship Fund V GP is the general partner of VentureLabs Rx V. Each of the reporting persons except for VentureLabs Rx V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
[F11]Shares held by Nutritional Health Side Fund, L.P. ("Nutritional Health Side Fund"). Flagship Fund V GP is the general partner of Nutritional Health Side Fund. Each of the reporting persons except for Nutritional Health Side Fund disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
[F12]Shares held by Nutritional Health Disruptive Innovation Fund, L.P. ("Nutritional Innovation Fund"). Flagship Fund V GP is the general partner of Nutritional Innovation Fund. Each of the reporting persons except for Nutritional Innovation Fund disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
[F2]Shares held by Flagship Fund IV. Flagship Ventures Fund IV General Partner LLC ("Flagship Fund IV GP") is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. ("Dr. Afeyan") is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
[F3]Shares held by Nutritional LTP. Nutritional Health LTP Fund General Partner LLC ("Nutritional LTP GP") is the general partner of Nutritional LTP. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Nutritional LTP GP. Dr. Afeyan is the Chief Executive Officer, director and sole stockholder of Flagship Pioneering. Each of the reporting persons except for Nutritional LTP disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
[F4]Shares held by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering is the manager of Flagship Fund VII GP. Each of the reporting persons except for Flagship Fund VII disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
[F5]Shares held by Flagship Ventures Fund IV-Rx, L.P ("Flagship Fund IV-Rx"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
[F6]Shares held by Flagship Ventures Opportunities Fund I, L.P. ("Flagship Opportunities I"). Flagship Ventures Opportunities Fund I General Partner LLC ("Flagship Opportunities GP") is the general partner of Flagship Opportunities I. Dr. Afeyan is the sole manager of Flagship Opportunities GP. Each of the reporting persons except for Flagship Opportunities I disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
[F7]Shares held by Flagship VentureLabs IV, LLC ("VentureLabs IV"). Flagship Fund IV is the manager of VentureLabs IV. Each of the reporting persons except for VentureLabs IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
[F8]Shares held by Flagship VentureLabs V LLC ("VentureLabs V"). Flagship VentureLabs V Manager LLC ("VentureLabs V Manager") serves as manager of VentureLabs V. Flagship Pioneering is the manager of VentureLabs V Manager. Each of the reporting persons except for VentureLabs V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
[F9]Shares held by Flagship Ventures Fund V, L.P. ("Flagship Fund V"). Flagship Ventures Fund V General Partner LLC ("Flagship Fund V GP") is the general partner of Flagship Fund V. Dr. Afeyan serves as sole manager of Flagship Fund V. Each of the reporting persons except for Flagship Fund V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Evelo Biosciences, Inc.

CIK 0001694665

→

Entity typeother

Related Parties

filerCIK 0001222012

Filing Metadata

Form type: 4
Filed: Jul 12, 8:00 PM ET
Accepted: Jul 13, 5:15 PM ET
Size: 31.9 KB

View on SEC.gov